Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Should WEE(1) CHK(1) in on the FAM(122A)ily?
    Editorial

    Caeser, R.; Sen, T.
    Molecular Cell (2020)

    Fulltext@MSK | Save
  • Evaluating of HPV-DNA ISH as an adjunct to p16 testing in oropharyngeal cancer
    Journal Article

    Chi, J.; Preeshagul, I. R.; Sheikh-Fayyaz, S.; Teckie, S.; Kohn, N.; Ziemba, Y.; Laser, A.; Frank, D.; Ghaly, M.; Kamdar, D.; more...
    Future Science OA (2020)

    Fulltext@MSK | Save
  • Targeting KRAS(G12C): From inhibitory mechanism to modulation of antitumor effects in patients
    Editorial

    Kim, D.; Xue, J. Y.; Lito, P.
    Cell (2020)

    Fulltext@MSK | Save
  • Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
    Journal Article

    Wells, D. K.; van Buuren, M. M.; Dang, K. K.; Hubbard-Lucey, V. M.; Sheehan, K. C. F.; Campbell, K. M.; Lamb, A.; Ward, J. P.; Sidney, J.; Blazquez, A. B.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • Larotrectinib versus prior therapies in tropomyosin receptor kinase fusion cancer: An intra-patient comparative analysis
    Journal Article

    Italiano, A.; Nanda, S.; Briggs, A.; Garcia-Foncillas, J.; Lassen, U.; Vassal, G.; Kummar, S.; van Tilburg, C. M.; Hong, D. S.; Laetsch, T. W.; more...
    Cancers (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
    Meeting Abstract

    Leyvraz, S.; Berlin, J.; Hong, D. S.; Deeken, J.; Valentina, B.; Oh, D. Y.; Patel, J.; Nanda, S.; Brega, N.; Childs, B. H.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Activity and safety of larotrectinib in adult patients with TRK fusion cancer: An expanded data set
    Meeting Abstract

    Leyvraz, S.; Drilon, A.; Farago, A. F.; Tan, D. S. W.; Kummar, S.; McDermott, R.; Berlin, J.; Patel, J.; Brose, M. S.; Tahara, M.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Quality of life of adults and children with TRK fusion cancer treated with larotrectinib compared to the general population
    Meeting Abstract

    Thorwarth, A.; Kummar, S.; van Tilburg, C. M.; Albert, C. M.; Berlin, J.; Farago, A. F.; McDermott, R.; Bielack, S.; Doz, F.; Dubois, S. G.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) + ipilimumab (IPI) versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1
    Meeting Abstract

    Thomas, M.; Ramalingam, S. S.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Schenker, M.; BernabeĢ Caro, R.; Lee, K. H.; Zurawski, B.; Audigier-Valette, C.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small-cell lung cancer
    Meeting Abstract

    Gautschi, O.; Goto, K.; Oxnard, G.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T.; Gainor, J.; McCoach, C.; Besse, B.; Cho, B. C.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save